Panurgy Drugs Private Limited
About Panurgy Drugs Private Limited
Data last updated:
Panurgy Drugs Private Limited is a private limited company based in Bathinda, Punjab, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 02 November 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231PB2004PTC027610. Its GSTIN is 03AADCP6394G1ZD (Punjab).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kuldip Singla and Ritu Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4969 Ist Floor Shiv Market Sadar Bazar, Bathinda, Punjab, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹82.97 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹1.11 Lakh (net margin -1.3%) and EBITDA of -₹39,759 (EBITDA margin -0.5%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Panurgy Drugs Private Limited's registered office is in Bathinda, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4969 Ist Floor Shiv Market Sadar Bazar, Bathinda, Punjab, India
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Panurgy Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Panurgy Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Panurgy Drugs Private Limited, buy the company report.
Financials of Panurgy Drugs Private Limited
FY 2025 filings availablePanurgy Drugs Private Limited reported revenue of ₹82.97 Lakh (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 14% fall in the latest year. EBITDA fell 324% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹39,759 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.5% | ||||
| Net Profit Margin | -1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Panurgy Drugs Private Limited, buy the company report.
Board of directors of Panurgy Drugs Private Limited
Panurgy Drugs has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kuldip Singla | Director | 02 Nov 2004 | 22 Years 0 Months | Current |
| Ritu Verma | Director | 02 Nov 2004 | 22 Years 0 Months | Current |
| Devinder Singh Sethi | Director | 02 Nov 2004 | 22 Years 0 Months | Current |
| Gangeshwer Bansal Also directs: Sidham Motors Private Limited | Director | 02 Nov 2004 | 22 Years 0 Months | Current |
Auditor
Panurgy Drugs Private Limited is audited by MOHAN & MOHAN for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOHAN & MOHAN | FY 2017 | 002612N |
Shareholding
The shareholding of Panurgy Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Panurgy Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Panurgy Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Panurgy Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Panurgy Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCP6394G1ZD | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Panurgy Drugs Private Limited, buy the company report.
Recent activity
Panurgy Drugs Private Limited has 4 board changes on record since 2004: 4 appointments. The latest: Devinder Singh Sethi was appointed as Director on 02 Nov 2004.
Frequently asked questions
Panurgy Drugs is an active private limited company based in Bathinda, Punjab, India. The company works in other wholesale, within the trading industry. It was incorporated on 02 November 2004 (22+ years old) and is registered under CIN U24231PB2004PTC027610.
Panurgy Drugs has 4 current directors:
- Kuldip Singla - Director
- Ritu Verma - Director
- Devinder Singh Sethi - Director
- Gangeshwer Bansal - Director
The latest financial statements of Panurgy Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Panurgy Drugs is 03AADCP6394G1ZD, registered in Punjab.
The CIN (Corporate Identification Number) of Panurgy Drugs is U24231PB2004PTC027610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Panurgy Drugs was incorporated on 02 November 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chandigarh.
Devinder Singh Sethi was appointed as Director on 02 Nov 2004. Gangeshwer Bansal was appointed as Director on 02 Nov 2004. Kuldip Singla was appointed as Director on 02 Nov 2004. Panurgy Drugs has 4 board changes on record in total.
The registered office of Panurgy Drugs is at 4969 Ist Floor Shiv Market Sadar Bazar, Bathinda, Punjab, India.
Panurgy Drugs operates in the trading industry, in the other wholesale segment.
The compliance status of Panurgy Drugs is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
